|
RAD17 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.242400E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.984300E-03 |
| Normal-vs-Stage2 |
1.305530E-02 |
| Normal-vs-Stage3 |
5.202500E-03 |
| Normal-vs-Stage4 |
3.307900E-02 |
| Stage1-vs-Stage2 |
6.608600E-01 |
| Stage1-vs-Stage3 |
4.026800E-01 |
| Stage1-vs-Stage4 |
5.457000E-01 |
| Stage2-vs-Stage3 |
7.821400E-01 |
| Stage2-vs-Stage4 |
7.679600E-01 |
| Stage3-vs-Stage4 |
9.561200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.633200E-04 |
| Normal-vs-AfricanAmerican |
7.138800E-03 |
| Normal-vs-Asian |
4.764600E-01 |
| Caucasian-vs-AfricanAmerican |
9.137600E-01 |
| Caucasian-vs-Asian |
4.839000E-01 |
| AfricanAmerican-vs-Asian |
5.414600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.560140E-04 |
| Normal-vs-Female |
3.219500E-02 |
| Male-vs-Female |
2.421600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.144640E-03 |
| Normal-vs-Extreme_Weight |
3.295400E-03 |
| Normal-vs-Obese |
1.877960E-03 |
| Normal-vs-Extreme_Obese |
8.166200E-02 |
| Normal_Weight-vs-Extreme_Weight |
3.364400E-01 |
| Normal_Weight-vs-Obese |
6.531200E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.316800E-01 |
| Extreme_Weight-vs-Obese |
5.963400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.624400E-01 |
| Obese-vs-Extreme_Obese |
9.265000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.508000E-02 |
| Normal-vs-Age(41-60Yrs) |
8.596000E-03 |
| Normal-vs-Age(61-80Yrs) |
2.439900E-04 |
| Normal-vs-Age(81-100Yrs) |
8.432400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.375600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.313400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.097400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.005800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.823200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.351200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.768200E-04 |
| Normal-VS-Type2 PRCC |
7.123200E-03 |
| Normal-VS-KIRP CIMP |
1.772930E-04 |
| Normal-VS-Unclassified PRCC |
6.310300E-02 |
| Type1 PRCC-VS-Type2 PRCC |
8.496600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.661300E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
7.192200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.106000E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
8.032800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.577900E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.078730E-03 |
| Normal-vs-N1 |
7.661700E-03 |
| Normal-vs-N2 |
6.165700E-02 |
| N0-vs-N1 |
8.515000E-01 |
| N0-vs-N2 |
4.341600E-01 |
| N1-vs-N2 |
5.524200E-01 |
|
|
